Lexaria Receives USD$2.6 Million Tax Rebate Payment
来源：TheNewswire发布于 2026-09-01
Lexaria's 2025 Australian human study results in a USD$2.6 million cash rebate Kelowna, British Columbia – September 1 , 2026 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“Lexaria” or th...
相关标的：LEXX
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。